Pharmacoeconomic analyses appear to account for differences in recommendations made regarding public payment when national bodies consider the same drugs for the same indication.
Barbara Mintzes, PhD
Advertisement
Articles by Barbara Mintzes, PhD
Advertisement
Latest Updated Articles
- Medicine Reimbursement Recommendations in Canada, Australia, and Scotland
Published: September 15th 2008 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
How Medicaid Reforms Could Deepen State Coverage Gaps
3
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
4
Flow Cytometry Tool Could Improve Treatment Monitoring in MS
5
